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A middle aged female presented with history of breathlessness and swelling of legs of 2 weeks
duration; the clinical and laboratory picture was suggestive of rapidly progressive renal failure
and the kidney biopsy revealed a crescentic glomerulonephritis. Her renal function improved
with the steroid therapy; in view of persistent breathlessness despite good diuresis chest radio-
graph was repeated which showed reduced lung volume on right and compensatory emphysema
on the left side; a computerized tomography (CT) scan of the thorax showed a mass lesion
partially obliterating the right main bronchial lumen. Themass on histopathology revealed small
cell neuroendocrine carcinoma (SCNC) with adenosquamous carcinoma.
To our knowledge only one case of neuroendocrine tumor presenting as a crescentic glomer-
ulonephritis has been reported in the literature.
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A 64-year-old female, a known case of essential hyperten-
sion of 25 years duration and type 2 diabetes mellitus &
bronchial asthma of 2 years duration, presented with
breathlessness, swelling of legs and hematuria, progres-
sively worsening over a period of 2 weeks. She was found to
Figure 2 Chest radiograph (postero-anterior view) showing
reduced lung volume with collapse on right side and compen-
satory emphysema on the left.
Combined neuroendocrine small cell carcinoma 229have pedal edema, her blood pressure was 140/90 mmHg
and the respiratory system examination on auscultation
revealed ronchi. Other systems were normal on
examination.
Her hemoglobin was 10 gm/dL, total leukocyte count
10,400/mm3 (66% neutrophils & 34% lymphocytes), plate-
lets 249,000/mm3 and erythrocyte sedimentation rate of
106 per hour. The blood urea was 100 mg/dL, serum
creatinine 3.8 mg/dL, sodium 139 meq/L, potassium
4 meq/L, calcium 8.7 mg/dL and phosphorus of 6.5 mg/dL.
Her blood sugar levels were within the normal range.
Urinalysis revealed proteinuria, numerous red blood cells
and 8e10 leukocytes per high power field; granular casts
were seen. Twenty-four hours urinary protein estimation
revealed 164 mg protein and the urine culture was sterile.
Complement levels were normal (C3 136 mg/dL and C4
48 mg/dL), both C and P antineutrophil cytoplasmic anti-
bodies (ANCA) were negative. An abdominal ultrasound
showed normal sized kidney.
The initial chest radiograph was suggestive of early
pulmonary edema. Electrocardiograph was normal and the
echocardiography showed concentric hypertrophy of the
left ventricle; ejection fraction was 69%.
The repeat renal function tests in the hospital revealed
rising serum creatinine over a week’s time, a clinical
diagnosis of rapidly progressive renal failure was considered
and kidney biopsy was done which on histopathology
showed crescentic glomerulonephritis (Fig. 1). She was
given pulse of intravenous methyl Prednisolone (500 mg/
day) over a period of 3 days, following which oral steroids
were started at 1 mg/kg body weight per day. Her renal
function started improving and the serum creatinine came
down to 1.5 mg/dL over a period of 10 days. However, she
continued to have breathlessness; a repeat chest radio-
graph was taken which showed reduced lung volume on
right side with compensatory emphysema on the left side
(Fig. 2). CT thorax revealed a mass partially obliterating the
right main bronchial lumen (Fig. 3). There were no lesions
in the lungs. The lesion on flexible bronchoscopy was found
to be a pedunculated mass arising from the carina and
partially obliterating the right main bronchus. ExcisionFigure 1 PAS stain 40X: photomicrograph showing a glomer-
ulus with the crescent.biopsy of the mass was done via rigid bronchoscopy and the
histopathology demonstrated the combined small cell
neuroendocrine carcinoma with adenosquamous carcinoma
(Fig. 4).
One month after the admission she received the first
cycle of chemotherapy (carboplatin and etoposide). On the
second day of chemotherapy her BP started dropping,
breathlessness increased and her chest radiograph showed
bilateral non-homogenous opacities; renal parameters
started worsening again and there was neutrophilicFigure 3 CT scan of the thorax (axial view) showing the mass
lesion partially obliterating the right main bronchial lumen.
Figure 4 H&E stain 40X: photomicrograph of tracheal tumor
showing small oval cells with hyperchromatic nucleus and
stippled chromatin suggestive of neuroendocrine carcinoma.
230 W.W. Baig et al.leukocytosis. Overall picture was of sepsis with multi-organ
dysfunction. Her BP continued to drop despite the iono-
tropic support and the empirical intravenous antibiotics
(teicoplanin and aztreonam). She died of septic shock after
1 week.
Discussion
The commonest site of presentation of SCNC is the lung;
other extra pulmonary sites being the esophagus, the larynx
and the head and neck. Primary laryngeal SCNC is a rare
entity accounting for less than 0.5% of the laryngeal
carcinomas. It is more common in men especially in
smokers. These tumors are well known for their paraneo-
plastic manifestations like EatoneLambert myasthenic
syndrome, syndrome of inappropriate secretion of anti-
diuretic hormone, and ectopic adrenocorticotropic
hormone syndrome.1
The paraneoplastic manifestation may be the first sign of
malignancy or the tumor may initially manifest with the
local symptoms like hoarseness of voice and a cervical
mass; about 50% of all patients with laryngeal SCNC have
cervical lymph node metastases at presentation and the
distant metastasis develops eventually in most. The diag-
nosis of these tumors is entirely based on the histopatho-
logical appearance and the confirmation is done by
immunocytochemical analysis. Concurrent chemo-
radiotherapy regimens offer potential for long-term
survival, however, this tumor is biologically aggressive, and
the stage of the disease is one of the most important
independent factors determining long-term survival.1,2
Paraneoplastic syndromes are classified into six types:
cutaneous, endocrine, hematological, neurological, rheu-
matologic, and ocular.2
Renalmanifestations of neuroendocrine small cell tumors
are rare. There are several case reports describing the
association of SCNC with nephrotic syndrome. Thecommonest lesion described is the membranous glomerulo-
nephritis (MGN).3e5 Our case is unique because the primary
neuroendocrine tumors of the trachea are rare and the renal
involvement as a paraneoplastic manifestation is unusual
and in most of the cases described the histopathology
showed MGN; only one case of crescentic glomerulonephritis
associated with NCSC has been reported in the literature.6
Another interesting feature is the presence of combined
histopathological picture (i.e. component of SCNC with
squamous cell carcinoma and/or adenocarcinoma).7 The
paraneoplastic syndromes have not been described in asso-
ciation with combined SCNC.1
Apart from the paraneoplastic effect these tumors can
also cause renal involvement by various other mechanisms
like direct infiltration or distant metastasis from the tumor
or secretory diarrhea (hormone induced) causing pre renal
type of acute renal failure.8,9
Chemoradiotherapy is the treatment of choice for SCNC.
Commonly used agents include cyclophosphamide, doxo-
rubicin hydrochloride and vincristine sulfate; cisplatin and
etoposide have been used with success.10
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